Jun Qi
Harvard University · 771 works · 26,092 citations · h-index 67
Top works
- Selective inhibition of BET bromodomains
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- The dTAG system for immediate and target-specific protein degradation
- Small-Molecule Inhibition of BRDT for Male Contraception
- BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
- Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
- BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
- Genome-wide determination of drug localization
- BET Bromodomain Inhibition of MYC -Amplified Medulloblastoma
- Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer
- Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
- Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
- Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
- An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
- Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA
- Acetylation site specificities of lysine deacetylase inhibitors in human cells